BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

645 related articles for article (PubMed ID: 15700631)

  • 21. Pathophysiology and treatment of ascites and the hepatorenal syndrome.
    Gentilini P; Laffi G
    Baillieres Clin Gastroenterol; 1992 Sep; 6(3):581-607. PubMed ID: 1421601
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New treatments of hepatorenal syndrome.
    Arroyo V; Terra C; Ginès P
    Semin Liver Dis; 2006 Aug; 26(3):254-64. PubMed ID: 16850375
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TIPS or vasoconstrictors for the treatment of hepatorenal syndrome type 1--effect on survival?
    Gülberg V; Gerbes AL
    Z Gastroenterol; 2002 Sep; 40(9):823-6. PubMed ID: 12215953
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hepatorenal syndrome].
    Pillebout E
    Nephrol Ther; 2014 Feb; 10(1):61-8. PubMed ID: 24388293
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatorenal syndrome.
    Bataller R; Ginès P; Guevara M; Arroyo V
    Semin Liver Dis; 1997; 17(3):233-47. PubMed ID: 9308128
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatorenal syndrome.
    Bataller R; Arroyo V; Ginès P; Sort P
    Forum (Genova); 1998; 8(1):62-81. PubMed ID: 9565447
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Review article: hepatorenal syndrome--how to assess response to treatment and nonpharmacological therapy.
    Arroyo V
    Aliment Pharmacol Ther; 2004 Sep; 20 Suppl 3():49-54; discussion 55-6. PubMed ID: 15335402
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatorenal syndrome: a severe, but treatable, cause of kidney failure in cirrhosis.
    Fagundes C; Ginès P
    Am J Kidney Dis; 2012 Jun; 59(6):874-85. PubMed ID: 22480795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathophysiology, clinical features and management of hepatorenal syndrome.
    Garzia P; Ferri GM; Ilardi M; Messina FR; Amoroso A
    Eur Rev Med Pharmacol Sci; 1998; 2(5-6):181-4. PubMed ID: 10710816
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ascites and hepatorenal syndrome: pathogenesis and treatment strategies.
    Ginès P; Arroyo V; Rodés J
    Adv Intern Med; 1998; 43():99-142. PubMed ID: 9506180
    [No Abstract]   [Full Text] [Related]  

  • 31. Pathophysiological basis of pharmacotherapy in the hepatorenal syndrome.
    Møller S; Bendtsen F; Henriksen JH
    Scand J Gastroenterol; 2005 May; 40(5):491-500. PubMed ID: 16036500
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Arachidonic acid derivatives and renal function in liver cirrhosis.
    Laffi G; La Villa G; Pinzani M; Marra F; Gentilini P
    Semin Nephrol; 1997 Nov; 17(6):530-48. PubMed ID: 9353864
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathogenesis of ascites and renal salt retention in cirrhosis.
    Palmer BF
    J Investig Med; 1999 May; 47(5):183-202. PubMed ID: 10361377
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The renin-angiotensin-aldosterone system in liver cirrhosis].
    Giudici Cipriani A; Folco U; Colombo P; Menardo G; Cattana A; Barbetti V; Rembado R; Marenco G
    Minerva Med; 1990; 81(1-2):45-53. PubMed ID: 2314615
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Complications of cirrhosis. II. Renal and circulatory dysfunction. Lights and shadows in an important clinical problem.
    Arroyo V; Jiménez W
    J Hepatol; 2000; 32(1 Suppl):157-70. PubMed ID: 10728802
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathophysiology, diagnosis and clinical management of hepatorenal syndrome: from classic to new drugs.
    Barbano B; Sardo L; Gigante A; Gasperini ML; Liberatori M; Giraldi GD; Lacanna A; Amoroso A; Cianci R
    Curr Vasc Pharmacol; 2014 Jan; 12(1):125-35. PubMed ID: 24678726
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Splanchnic and systemic vasodilatation: the patient.
    Tsai MH
    J Clin Gastroenterol; 2007; 41 Suppl 3():S266-71. PubMed ID: 17975476
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatorenal syndrome.
    Guevara M; Ginès P
    Dig Dis; 2005; 23(1):47-55. PubMed ID: 15920325
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Hepatorenal syndrome in patients with liver cirrhosis].
    Zaza S; Bonny O; Liaudet L
    Nephrol Ther; 2005 Jul; 1(3):174-82. PubMed ID: 16895684
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathogenesis of water and sodium retention in cirrhosis.
    Martin PY; Schrier RW
    Kidney Int Suppl; 1997 Jun; 59():S43-9. PubMed ID: 9185104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.